SavedAdd your journal

Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2011 / Cilt: 8 - Sayı: 1

Prognostic factors in epithelial ovarian carcinoma: A reference ınstitution experience

Epitelial over kanserlerinde prognostik faktörler: Bir referans merkezinin deneyimi

Ömer T. YALÇIN
S. Sinan ÖZALP
Tufan ÖGE
Pages
51–56
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aim: To evaluate epimediologic and prognostic factors of the patients with epithelial ovarian cancer retrospectively and to investigate the factors that effect overall survival.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate epimediologic and prognostic factors of the patients with epithelial ovarian cancer retrospectively and to investigate the factors that effect overall survival.
📊
Key Findings & Data:Material and Method: Between January 1990 and December 2004, 149 patients with malign epithelial ovarian tumor were included to this study.
💡
Conclusion & Impact:Maximal diameter of residual tumor was 1cm and no residual tumor were obtained to be 54.8 months, 22.7 months and 43.5 months respectively (p
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate epimediologic and prognostic factors of the patients with epithelial ovarian cancer retrospectively and to investigate the factors that effect overall survival. Material and Method: Between January 1990 and December 2004, 149 patients with malign epithelial ovarian tumor were included to this study. Age, parity, primary complaint and postoperative histopathology, surgical stage and maximal diameter of residual tumor of the patients were obtained and factors that effect overall survival were evaluated. Results: Mean age of the patients was 52.8 ± 13 years. Most of the patients were multipar (85.9%) and most fruquent (n: 88) (59.1%) complaint was abdominal swelling. Postoperative surgical stages were stage I in 24 (16.1%), stage II in11 (7.4%), stage III in 87 (58.4%) and stage IV in 27 (18.1%) patients. Maximal diameter of residual tumor was 1cm and no residual tumor were obtained to be 54.8 months, 22.7 months and 43.5 months respectively (p

Özet

Amaç: Over kanserli vakaları retrospektif olarak inceleyerek, epidemiyolojik ve prognostik faktörleri araştırmak ve sağkalıma etki eden parametreleri incelemek. Gereç ve Yöntem: Ocak 1990 - Aralık 2004 tarihleri arasında kliniğimizde takibi yapılan 149 malign epitelial over tümörlü vaka incelendi. Hastaların yaşı, paritesi, primer şikayetleri, postoperatif tümör histopatolojileri, cerrahi evreleri ve maksimum rezidü tümör çapları kayıt edilerek bu parametlerin sağkalımlarına etkisi değerlendirilmiştir. Bulgular: Hastaların ortalama tanı yaşı 52.8 ± 13 yıl olarak saptanmıştır. Olguların büyük çoğunluğu (%85.9) multipar olup, en sık şikayet (n: 88 %59.1) karın şişliği olarak tespit edilmiştir. Cerrahi sonrası hastaların 24'ü (%16.1) evre I, 11'i (%7.4) evre II, 87'si (%58.4) evre III ve 27'si (%18.1) evre IV ve rezidü tümör çapları, maksimum 1 cm olan 68 (%45.6), 1 cm ve üzerine olan 57 hasta (%38.3) saptanmış, 24 hastada ise (%16.1) rezidü tümör kalmadığı saptanmıştır. Histopatolojik olarak: seröz ( %53.6), endometrioid (%16.7), müsinöz (%10.7), berrak hücreli (%10.7), diğer (% 7.8) tespit edilmiştir. Yaşı 0.05). Postoperatif rezidü tümörü kalmayan grupta ortalama yaşam süresi 43.5 ay bulunurken, 1 cm’nin altı ve 1 cm.nin üstünde tümör kalan gruplarda ise ortalama yaşam süresi sırasıyla 54.8 ve 22.7 ay olarak bulunmuştur. (p

🔖

Cite This Article

YALÇIN, Ö. T., ÖZALP, S. S., ÖGE, T. (2022). Prognostic factors in epithelial ovarian carcinoma: A reference ınstitution experience. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 8 - Sayı: 1, 51–56. https://ajindex.com/articles/631603

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106-30
  2. Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol 2009; 472: 413- 37
  3. Webb PM, Purdie DM, Grover S, Jordan S, Dick ML, Green AC. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol 2004; 92: 232- 9
  4. Hennessy BT, Coleman RL, Markman M. Ovarian cancer. Lancet 2009; 374: 1371- 82
  5. Eisenkop SM, Spirtos NM, Lin WC. ''Optimal'' cytoreduction for advanced epithelial ovarian cancer: a commentary. Gynrcol Oncol 2006; 103: 329- 35
  6. Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 1993; 71: 517- 23
  7. Scholz HS, Benedicic C, Haas J, Tamussino K, Petru E. Stage IV ovarian cancer: prognostic factors and survival beyond 5 years. Anticancer Res 2001; 21: 3729- 32
  8. Merino MJ, Jaffe G. Age contrast in ovarian pathology. Cancer 1993; 71: 537- 44
  9. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obstet Gynecol 2001; 98: 212- 7
  10. Brun JL, Feyler A, Chene G, Saurel J, Brun G, Hocke C. Longterm results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 2000; 78: 21- 7
  11. Board RE, Bruijns CT, Pronk AE, Ryder WD, Wilkinson PM, Welch R,et al. Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center. Int J Gynecol Cancer 2006; 16 Suppl 1: 18- 24
  12. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006; 107: 77- 85
  13. Bailey J, Murdoch J, Anderson R, Weeks J, Foy C. Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998. Int J Gynecol Cancer 2006; 16 Suppl 1: 25- 9
  14. Aletti GD, Gostout BS, Podratz KC, Cliby WA. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol 2006; 100: 33- 7
  15. Bozas G, Dimopoulos MA, Kastritis E, Efstathiou E, Koutsoukou V, Rodolakis A, et al. Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: A single institution experience. Oncology 2006; 70: 265- 72
  16. Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF,